机构：[1]Center for Human Experimental Therapeutics, University of Rochester Medical Center, Rochester, New York, USA[2]Northwest Neurological, PLLC, Spokane, Washington, USA[3]Department of Neurology, Johns Hopkins Medicine, Baltimore, Maryland, USA[4]Radboud University Medical Center, Donders Institute for Brain, Cognition and Behavior, Department of Neurology, Nijmegen, the Netherlands[5]Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA[6]Department of Neurology and Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing Key Laboratory on Parkinson’s Disease, Parkinson’s Disease Center of Beijing Institute for Brain Disorders, Beijing, China神经内科首都医科大学宣武医院[7]Neurology Department, Hospital Universitario, Burgos, Spain[8]Rush University Medical Center, Chicago, Illinois, USA[9]University of Toronto, Division of Neurology, Centre for Movement Disorders, Markham, Ontario, Canada[10]Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA[11]Kaiser Permanente Movement Disorders Program, Northern California, USA[12]Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA[13]Parkinson’s Disease Research, Education and Clinical Center, San Francisco Veterans Affairs Medical Center and Department of Neurology, University of California–San Francisco, San Francisco, California, USA[14]Department of Medicine, North Tyneside General Hospital, Rake Lane, North Shields, Tyne and Wear, United Kingdom[15]Department of Neurology, Department of Veterans Affairs, Philadelphia, Pennsylvania, USA
Travel distance, growing disability, and uneven distribution of doctors limit access to care for most Parkinson's disease (PD) patients worldwide. Telemedicine, the use of telecommunications technology to deliver care at a distance, can help overcome these barriers. In this report, we describe the past, present, and likely future applications of telemedicine to PD. Historically, telemedicine has relied on expensive equipment to connect single patients to a specialist in pilot programs in wealthy nations. As the cost of video conferencing has plummeted, these efforts have expanded in scale and scope, now reaching larger parts of the world and extending the focus from care to training of remote providers. Policy, especially limited reimbursement, currently hinders the growth and adoption of these new care models. As these policies change and technology advances and spreads, the following will likely develop: integrated care networks that connect patients to a wide range of providers; education programs that support patients and health care providers; and new research applications that include remote monitoring and remote visits. Together, these developments will enable more individuals with PD to connect to care, increase access to expertise for patients and providers, and allow more-extensive, less-expensive participation in research. (C) 2014 International Parkinson and Movement Disorder Society
基金：
Davis Phinney Foundation; Great Lakes NeuroTechnologies; Michael J. Fox Foundation; Patient-Centered Outcomes Research Institute
第一作者机构：[1]Center for Human Experimental Therapeutics, University of Rochester Medical Center, Rochester, New York, USA
通讯作者：
通讯机构：[*1]Center for Human Experimental Therapeutics, University of Rochester Medical Center, 265 Crittenden Boulevard, CU 420694, Rochester, NY 14642, USA
推荐引用方式(GB/T 7714)：
Meredith Achey ,Jason L. Aldred ,Noha Aljehani ,et al.The Past, Present, and Future of Telemedicine for Parkinson's Disease[J].MOVEMENT DISORDERS.2014,29(7):871-883.doi:10.1002/mds.25903.
APA：
Meredith Achey,,Jason L. Aldred,,Noha Aljehani,,Bastiaan R. Bloem,,Kevin M. Biglan,...&Jayne R. Wilkinson,.(2014).The Past, Present, and Future of Telemedicine for Parkinson's Disease.MOVEMENT DISORDERS,29,(7)
MLA：
Meredith Achey,,et al."The Past, Present, and Future of Telemedicine for Parkinson's Disease".MOVEMENT DISORDERS 29..7(2014):871-883
医学